New Series of VEGFR-2 Inhibitors and Apoptosis Enhancers: Design, Synthesis and Biological Evaluation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New Series of VEGFR-2 Inhibitors and Apoptosis Enhancers: Design, Synthesis and Biological Evaluation
Authors
Keywords
-
Journal
Drug Design Development and Therapy
Volume Volume 16, Issue -, Pages 587-607
Publisher
Informa UK Limited
Online
2022-03-02
DOI
10.2147/dddt.s344750
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis and Vasorelaxant Evaluation of Novel 7-Methoxyl-2,3-disubstituted-quinoxaline Derivatives
- (2021) Chang-Bo Zheng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Design, synthesis and molecular modeling of new quinazolin-4(3H)-one based VEGFR-2 kinase inhibitors for potential anticancer evaluation
- (2021) Abdallah E. Abdallah et al. BIOORGANIC CHEMISTRY
- Novel Nanocombinations of l-Tryptophan and l-Cysteine: Preparation, Characterization, and Their Applications for Antimicrobial and Anticancer Activities
- (2021) Ahmed I. Abd-Elhamid et al. Pharmaceutics
- Gallic acid potentiates the apoptotic effect of paclitaxel and carboplatin via overexpression of Bax and P53 on the MCF‐7 human breast cancer cell line
- (2020) Nora M. Aborehab et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Design, synthesis and biological evaluation of isochroman-4-one hybrids bearing piperazine moiety as antihypertensive agent candidates
- (2019) Shaowen Xie et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Functional characterization of α7 nicotinic acetylcholine and NMDA receptor signaling in SH-SY5Y neuroblastoma cells in an ERK phosphorylation assay
- (2018) Mohamed R. Elnagar et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Piperazinyl fragment improves anticancer activity of Triapine
- (2018) Marta Rejmund et al. PLoS One
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The multikinase inhibitor regorafenib decreases angiogenesis and improves portal hypertension
- (2018) Frank Erhard Uschner et al. Oncotarget
- Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors
- (2017) Mona A. Abdullaziz et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Simple access to spirooxadiazole compounds containing a quinoxaline moiety using a nitrile imine intermediate generated in situ
- (2017) Abdolali Alizadeh et al. HETEROCYCLIC COMMUNICATIONS
- Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy
- (2017) Keehoon Jung et al. JOURNAL OF CLINICAL INVESTIGATION
- Vatalanib, a tyrosine kinase inhibitor, decreases hepatic fibrosis and sinusoidal capillarization in CCl4-induced fibrotic mice
- (2017) Ling-Jian Kong et al. Molecular Medicine Reports
- 1-Piperazinylphthalazines as potential VEGFR-2 inhibitors and anticancer agents: Synthesis and in vitro biological evaluation
- (2016) Sahar M. Abou-Seri et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- VEGF induces signalling and angiogenesis by directing VEGFR2 internalisation via macropinocytosis.
- (2016) Dimitris Basagiannis et al. JOURNAL OF CELL SCIENCE
- Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents
- (2016) Marwa A. Aziz et al. Scientific Reports
- The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression
- (2016) Jiandong Chen Cold Spring Harbor Perspectives in Medicine
- Synthesis, antiangiogenesis evaluation and molecular docking studies of 1-aryl-3-[(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas: Discovery of a new substitution pattern for type II VEGFR-2 Tyr kinase inhibitors
- (2015) Vera A. Machado et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis
- (2015) Stéphanie Herkenne et al. Science Signaling
- Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy
- (2015) Wen Wen Xu et al. Oncotarget
- The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis
- (2015) Stéphanie Herkenne et al. Science Signaling
- Design, synthesis and biological evaluation of type-II VEGFR-2 inhibitors based on quinoxaline scaffold
- (2014) Mai I. Shahin et al. BIOORGANIC CHEMISTRY
- Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial
- (2014) Vivek Subbiah et al. Journal of Hematology & Oncology
- Type II Kinase Inhibitors: An Opportunity in Cancer for Rational Design
- (2013) Javier Blanc et al. Anti-Cancer Agents in Medicinal Chemistry
- Risk of hypertension with regorafenib in cancer patients: a systematic review and meta-analysis
- (2013) Zexing Wang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- A development of chimeric VEGFR2 TK inhibitor based on two ligand conformers from PDB: 1Y6A complex – Medicinal chemistry consequences of a TKs analysis
- (2013) Lucia Lintnerová et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Expression and prognostic value of VEGFR-2, PDGFR-β, and c-Met in advanced hepatocellular carcinoma
- (2013) Jie Sheng Chu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Synthesis of piperazinyl benzothiazole/benzoxazole derivatives coupled with 1,3,4-oxadiazole-2-thiol: novel hybrid heterocycles as anticancer agents
- (2013) M. S. R. Murty et al. MEDICINAL CHEMISTRY RESEARCH
- Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study
- (2012) D Strumberg et al. BRITISH JOURNAL OF CANCER
- HIFs, angiogenesis, and cancer
- (2012) Yongzhi Yang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors
- (2010) Kyungik Lee et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Antiangiogenic Cancer Therapy: Monitoring with Molecular US and a Clinically Translatable Contrast Agent (BR55)
- (2010) Marybeth A. Pysz et al. RADIOLOGY
- Through the “Gatekeeper Door”: Exploiting the Active Kinase Conformation
- (2009) Fabio Zuccotto et al. JOURNAL OF MEDICINAL CHEMISTRY
- High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer
- (2008) Sriparna Ghosh et al. HUMAN PATHOLOGY
- Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor†
- (2008) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacophore modeling studies of type I and type II kinase inhibitors of Tie2
- (2008) Qing-Qing Xie et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis
- (2008) Shenhong Wu et al. LANCET ONCOLOGY
- Luminescent Biological Probes Derived from Ruthenium(II) Estradiol Polypyridine Complexes
- (2007) Kenneth Kam-Wing Lo et al. INORGANIC CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now